Reset
Sat
Aug
02 Sun
Aug
03 Mon
Aug
04 Tue
Aug
05 Wed
Aug
06
Time Room Session
08:15-09:30 155
155
08:15
Invited Symposia: Global Perspectives on Management of Alcohol-Associated Liver Disease and Alcohol Use Disorder
Full Details
Brian Lee, United States
LT Recipient Selection for AAH vs AALD
Brian Lee, United States
LT Recipient Selection for AAH vs AALD
Yael Belinkie, United States
AUD Management and Culturally Appropriate Considerations
Yael Belinkie, United States
AUD Management and Culturally Appropriate Considerations
Kathryn Horwath, United States
Post-LT Relapse: Management & Prevention
Kathryn Horwath, United States
Post-LT Relapse: Management & Prevention
Luis Diaz, United States
Global Differences in AAH/ALD Management Including Non-Transplant Liver Replacement Therapy
Luis Diaz, United States
Global Differences in AAH/ALD Management Including Non-Transplant Liver Replacement Therapy
08:15-09:30 10
10
08:15
Invited Symposia: Extracellular Vesicles - Small but Powerful with Broad Consequences
Full Details
Marie-Josée Hébert, Canada
Immune Consequences of Apoptosis Generated EVs
Marie-Josée Hébert, Canada
Immune Consequences of Apoptosis Generated EVs
Jamil Azzi, United States
EVs as Biomarkers in Transplantation
Jamil Azzi, United States
EVs as Biomarkers in Transplantation
Sheri Krams, United States
Role of EVs in Allotransplantation and Tolerance
Sheri Krams, United States
Role of EVs in Allotransplantation and Tolerance
Raghu Kalluri, United States
New Insight into the Biology and Function of Extracellular Vesicles in Cancer
Raghu Kalluri, United States
New Insight into the Biology and Function of Extracellular Vesicles in Cancer
08:15-09:30 22
22
08:15
Invited Symposia: Hot Topics in Pediatric Transplantation
Full Details
Stephen Alexander, Australia
Tolerance for Pediatric Transplant Recipients
Stephen Alexander, Australia
Tolerance for Pediatric Transplant Recipients
Blayne Amir Sayed, Canada
Splitter vs. Lumper: Split Liver Transplantation for Pediatrics
Blayne Amir Sayed, Canada
Splitter vs. Lumper: Split Liver Transplantation for Pediatrics
Kevin Downes, United States
Increasing Pediatric Transplant Participation in Clinical Trials
Kevin Downes, United States
Increasing Pediatric Transplant Participation in Clinical Trials
Emily Perito, United States
Update in Pediatric Liver Transplant Allocation
Emily Perito, United States
Update in Pediatric Liver Transplant Allocation
08:15-09:30 20
20
08:15
Invited Symposia: Lung Transplant Hot Topic Debate
Full Details
Andrew Courtwright, United States
Lung Transplant for ARDS - Is It Worth It? CON
Andrew Courtwright, United States
Lung Transplant for ARDS - Is It Worth It? CON
Ankit Bharat, United States
Lung Transplant for Cancer - Should It Be Done? PRO
Ankit Bharat, United States
Lung Transplant for Cancer - Should It Be Done? PRO
Konrad Hoetzenecker, United States
Lung Transplant for Cancer - Should It Be Done? CON
Konrad Hoetzenecker, United States
Lung Transplant for Cancer - Should It Be Done? CON
Rade Tomic, United States
Lung Transplant For ARDS - Is it Worth it? Pro
Rade Tomic, United States
Lung Transplant For ARDS - Is it Worth it? Pro
08:15-09:30 4
4
08:15
Invited Symposia: Living Donor Medical and Surgical Selection
Full Details
Neetika Garg, United States
The Hypertensive Donor and the Risk of Post-Donation Hypertension
Neetika Garg, United States
The Hypertensive Donor and the Risk of Post-Donation Hypertension
Babak Orandi, United States
The Obese Donor
Babak Orandi, United States
The Obese Donor
Emilio Poggio, United States
Kidney Function Assessment
Emilio Poggio, United States
Kidney Function Assessment
Mona Doshi, United States
Kidney Function in Older Donors (What Is Normal and Acceptable)
Mona Doshi, United States
Kidney Function in Older Donors (What Is Normal and Acceptable)
08:15-09:30 23
23
08:15
Invited Symposia: Ensuring the Quality and Safety of Deceased Donor Services
Full Details
Darren Malinoski, United States
Harnessing Big Data to Improve Deceased Donor Management
Darren Malinoski, United States
Harnessing Big Data to Improve Deceased Donor Management
Clive Callender, United States
Cultural Safety in Deceased Donation
Clive Callender, United States
Cultural Safety in Deceased Donation
Maria Gomez, United Arab Emirates
Metrics - Beyond Donor Rate per Million and the Critical Pathway
Maria Gomez, United Arab Emirates
Metrics - Beyond Donor Rate per Million and the Critical Pathway
Bartira De Aguiar Roza, Brazil
Ensuring Safety - Biovigilance
Bartira De Aguiar Roza, Brazil
Ensuring Safety - Biovigilance
08:15-09:30 9
9
08:15
Invited Symposia: Stem-Cell Derived Islet Clusters for Diabetes: How Close Is the Future?
Full Details
Sonja Schrepfer, United States
Knocking Out the HLA: A Viable Strategy for Making Hypoimmune Islets?
Sonja Schrepfer, United States
Knocking Out the HLA: A Viable Strategy for Making Hypoimmune Islets?
Erik Finger, United States
Supercooling Stem Cell Derived Islets to Facilitate Clinical Translation
Erik Finger, United States
Supercooling Stem Cell Derived Islets to Facilitate Clinical Translation
Jon Odorico, United States
Stem-Cell Derived Islets: Status of Clinical Trials
Jon Odorico, United States
Stem-Cell Derived Islets: Status of Clinical Trials
08:15-09:30 25
25
08:15
Invited Symposia: Assessment of Deceased Donor Organ Viability and Longevity
Full Details
Darren Stewart, United States
Artificial Intelligence Strategies
Darren Stewart, United States
Artificial Intelligence Strategies
Lakshman Gunaratnam, Canada
Biomarkers
Lakshman Gunaratnam, Canada
Biomarkers
Dixon Kaufman, United States
Patient Selection Considerations
Dixon Kaufman, United States
Patient Selection Considerations
Maziar Riazy, Canada
The Deceased Donor Kidney Biopsy
Maziar Riazy, Canada
The Deceased Donor Kidney Biopsy
08:15-09:30 24
24
08:15
Invited Symposia: Recovering from Innovation Stagnation – Leveraging Global Regulatory Pathways for New Therapeutic Approvals in Solid Organ Transplant
Full Details
Karin Hehenberger, United States
Transplant Recipient Perspective - Where Are Endpoints and New Therapies Falling Short?
Karin Hehenberger, United States
Transplant Recipient Perspective - Where Are Endpoints and New Therapies Falling Short?
Bill Fitzsimmons, United States
Comparing and Contrasting Expedited Development Pathways in US, EU, and ROW
Bill Fitzsimmons, United States
Comparing and Contrasting Expedited Development Pathways in US, EU, and ROW
Timothy Schroeder, United States
Strategies for Developing a New Therapeutic in Multinational Trials to Address the Needs of Global Regulators
Timothy Schroeder, United States
Strategies for Developing a New Therapeutic in Multinational Trials to Address the Needs of Global Regulators
Stefan Schneeberger, Austria
Kidney NMP and Trial Perspectives and Endpoints
Stefan Schneeberger, Austria
Kidney NMP and Trial Perspectives and Endpoints
08:15-09:15 12
12
08:15
Invited Symposia: Xenotransplantation - Basic Mechanisms on the Way to Clinical Success
Full Details
Paige Porrett, United States
Innate Immune Infiltration of Xenografts
Paige Porrett, United States
Innate Immune Infiltration of Xenografts
Steven Kim, United States
NK Cells in NHP Xenografts
Steven Kim, United States
NK Cells in NHP Xenografts
Brendan Keating, United States
NK Cells in Human Decedent Model
Brendan Keating, United States
NK Cells in Human Decedent Model
08:15-09:15 153
153
08:15
Invited Symposia: Fungal Busters: Navigating the Moldy Maze of Antifungals
Full Details
Ashley Feist, United States
Antifungal Drug Interactions: Management Pearls
Ashley Feist, United States
Antifungal Drug Interactions: Management Pearls
Shahid Husain, Canada
Optimizing Antifungal Durations: Prophylaxis, Pre-emptive, Definitive Treatment
Shahid Husain, Canada
Optimizing Antifungal Durations: Prophylaxis, Pre-emptive, Definitive Treatment
Shmuel Shoham, United States
Using Novel Antifungals: First Line or Salvage
Shmuel Shoham, United States
Using Novel Antifungals: First Line or Salvage
08:15-09:15 8
8
08:15
Invited Symposia: Recurrent Glomerular Disease Post Kidney Transplant: Navigating New Frontiers in IgA Nephropathy, FSGS, Membranous Nephropathy, and MPGN - Session 2
Full Details
Song Ong, United States
IgAN-Recurrence: Overview of New Biomarkers, Evolving Diagnostics, Emerging Therapies
Song Ong, United States
IgAN-Recurrence: Overview of New Biomarkers, Evolving Diagnostics, Emerging Therapies
Sami Alasfar, United States
Recurrent MPGN and C3 Glomerulopathy: Understanding Recurrence and Complement-Targeted Therapies
Sami Alasfar, United States
Recurrent MPGN and C3 Glomerulopathy: Understanding Recurrence and Complement-Targeted Therapies
08:15-09:30 21
21
08:15
Invited Symposia: Value Based Care in Liver Transplantation: Learning from Global Perspectives to Guide Best Practices
Full Details
Madhukar Patel, United States
Defining Value and Blueprint to the Future
Madhukar Patel, United States
Defining Value and Blueprint to the Future
Abdul Hakeem, United Kingdom
The Pros and Cons of Transplant in a National Payer Model
Abdul Hakeem, United Kingdom
The Pros and Cons of Transplant in a National Payer Model
Ashwin Rammohan, India
The Pros and Cons of Transplant in a Private Payer Model
Ashwin Rammohan, India
The Pros and Cons of Transplant in a Private Payer Model
Markus Selzner, Canada
Considerations for Adopting Innovation and Optimizing Education in Value-Based Care Model
Markus Selzner, Canada
Considerations for Adopting Innovation and Optimizing Education in Value-Based Care Model
08:15-09:30 11
11
08:15
Oral Abstract: Advances in HLA Research
Full Details
Kevin Louis, France
Value of HLA Class II Combined Molecular Mismatch Score for Immune Risk Stratification in Kidney Transplantation
Kevin Louis, France
Value of HLA Class II Combined Molecular Mismatch Score for Immune Risk Stratification in Kidney Transplantation
Shengli Song, United States
A 64-Plex Single-HLA Reporter Cell Panel for Characterizing Allo-Specific B-Cell Responses
Shengli Song, United States
A 64-Plex Single-HLA Reporter Cell Panel for Characterizing Allo-Specific B-Cell Responses
Dennis van den Broek, Netherlands
Dissecting HLA-DQ Immunogenicity: Validating the Impact of HLA-DQα05 Heterodimer and HLA-DQ Evolutionary Divergent Mismatches in Kidney Transplant Recipients with Two Mismatches yet One Donor-Specific Antibody
Dennis van den Broek, Netherlands
Dissecting HLA-DQ Immunogenicity: Validating the Impact of HLA-DQα05 Heterodimer and HLA-DQ Evolutionary Divergent Mismatches in Kidney Transplant Recipients with Two Mismatches yet One Donor-Specific Antibody
YIPING JIN, United States
TLR4 Regulates HLA-II Antibody-Mediated P-selectin Expression and Monocyte Capture to Human Endothelial Cells in a Piezo1 Dependent Manner
YIPING JIN, United States
TLR4 Regulates HLA-II Antibody-Mediated P-selectin Expression and Monocyte Capture to Human Endothelial Cells in a Piezo1 Dependent Manner
Masaaki Hirata, United States
Development of a Cross-Organ Predictive Model for De Novo Donor-Specific Antibody Based on Differential Risk Assessment of Individual HLA Eplet Mismatches
Masaaki Hirata, United States
Development of a Cross-Organ Predictive Model for De Novo Donor-Specific Antibody Based on Differential Risk Assessment of Individual HLA Eplet Mismatches
Marcelo Fernandez-Vina, United States
2025 Novel Designation of Serologic HLA Antigens, Their Implications in Organ Allocation and Humoral Sensitization Assessment
Marcelo Fernandez-Vina, United States
2025 Novel Designation of Serologic HLA Antigens, Their Implications in Organ Allocation and Humoral Sensitization Assessment
Andrés Jaramillo, United States
Virtual Crossmatching: Is Physical Crossmatching Still Necessary?
Andrés Jaramillo, United States
Virtual Crossmatching: Is Physical Crossmatching Still Necessary?
Luis Hidalgo, United States
Surrogate Crossmatch Verification of De Novo DSA Development to Define the True DSA Incidence
Luis Hidalgo, United States
Surrogate Crossmatch Verification of De Novo DSA Development to Define the True DSA Incidence
08:15-09:30 154
154
08:15
Oral Abstract: Deceased Donor Kidney General Outcomes
Full Details
Alan Xu, Australia
Comparable Long-Term Outcomes Between Donation After Circulatory Death versus Neurological Death Donors for Kidney Transplant Recipients: An Australian and New Zealand Dialysis and Transplant Registry (ANZDATA) Study
Alan Xu, Australia
Comparable Long-Term Outcomes Between Donation After Circulatory Death versus Neurological Death Donors for Kidney Transplant Recipients: An Australian and New Zealand Dialysis and Transplant Registry (ANZDATA) Study
James Rogers, United States
Outcomes of Hepatitis B Viremic Donor Kidney Transplants in Seronegative Recipients: An Analysis of National Registry Data
James Rogers, United States
Outcomes of Hepatitis B Viremic Donor Kidney Transplants in Seronegative Recipients: An Analysis of National Registry Data
Joshua Vergin, United States
Survival Benefit of Kidney Transplantation in the Modern Era
Joshua Vergin, United States
Survival Benefit of Kidney Transplantation in the Modern Era
Junichiro Sageshima, United States
Time-Dependent Impact of Deceased-Donor and Graft Risk Factors on Kidney Allograft Survival
Junichiro Sageshima, United States
Time-Dependent Impact of Deceased-Donor and Graft Risk Factors on Kidney Allograft Survival
Juan Pablo Huidobro Espinosa, United States
Equal Clinical Outcomes and Favorable Histopathological Findings in Kidneys from Donors with Acute Kidney Injury
Juan Pablo Huidobro Espinosa, United States
Equal Clinical Outcomes and Favorable Histopathological Findings in Kidneys from Donors with Acute Kidney Injury
Elizabeth Hendren, Canada
The Kidney Donor Profile Index (KDPI) is Associated with Kidney Allograft Function (eGFR) at One Year After Transplant but Not with the Subsequent Change in Kidney Allograft Function (eGFR Slope)
Elizabeth Hendren, Canada
The Kidney Donor Profile Index (KDPI) is Associated with Kidney Allograft Function (eGFR) at One Year After Transplant but Not with the Subsequent Change in Kidney Allograft Function (eGFR Slope)
Anu Murthy, United States
One Year Graft and Patient Outcomes from Deceased Kidney Donors on Dialysis: A Single Center Experience
Anu Murthy, United States
One Year Graft and Patient Outcomes from Deceased Kidney Donors on Dialysis: A Single Center Experience
Laura Matuschik, Germany
Prolonged Cold Ischemia Time is a Risk Factor for Delayed Graft Function and Increased Mortality in Kidney Transplant Recipients within the Eurotransplant Senior Program
Laura Matuschik, Germany
Prolonged Cold Ischemia Time is a Risk Factor for Delayed Graft Function and Increased Mortality in Kidney Transplant Recipients within the Eurotransplant Senior Program
10:00-10:30 Plenary
Plenary
10:00
Transplant Under Stress: Operating in a Warzone - Borys Todurov
Full Details
Borys Todurov, Ukraine
Transplant Under Stress: Operating in a Warzone
Borys Todurov, Ukraine
Transplant Under Stress: Operating in a Warzone
10:30-11:30 Plenary
Plenary
10:30
Plenary: Plenary Abstracts 2
Full Details
Thomas Wekerle, Austria
A Phase I/II Trial Investigating Autologous Polyclonal Treg Therapy Together with Donor Bone Marrow Infusion in HLA-Mismatched Kidney Transplantation
Thomas Wekerle, Austria
A Phase I/II Trial Investigating Autologous Polyclonal Treg Therapy Together with Donor Bone Marrow Infusion in HLA-Mismatched Kidney Transplantation
Chase Wehrle, United States
Hypothermic-Oxygenated and Normothermic Machine Perfusion: A Risk-Matched Post-Hoc Comparison of the Bridge to Hope Randomized Trial with Prospectively Collected Institutional Outcomes
Chase Wehrle, United States
Hypothermic-Oxygenated and Normothermic Machine Perfusion: A Risk-Matched Post-Hoc Comparison of the Bridge to Hope Randomized Trial with Prospectively Collected Institutional Outcomes
Sara Alibrandi, United States
Exosome-Mediated Allorecognition is Complement Dependent
Sara Alibrandi, United States
Exosome-Mediated Allorecognition is Complement Dependent
Julianna Buchwald, United States
A Change of Heart: siRNA-Mediated Gene Silencing and Delivery during Ex Vivo Heart Perfusion for Organ Optimization
Julianna Buchwald, United States
A Change of Heart: siRNA-Mediated Gene Silencing and Delivery during Ex Vivo Heart Perfusion for Organ Optimization
11:30-12:45 Plenary
Plenary
11:30
Presidential Addresses: ASTS Presidential Address & Society Awards
Full Details
Elizabeth Pomfret, United States
President Intro
Elizabeth Pomfret, United States
President Intro
Ginny Bumgardner, United States
Presidents Address
Ginny Bumgardner, United States
Presidents Address
Thomas Peters, United States
Intro to Grants Ceremony
Thomas Peters, United States
Intro to Grants Ceremony
Thomas Peters, United States
Foundation Grants: Faculty Development Grant
Thomas Peters, United States
Foundation Grants: Faculty Development Grant
Thomas Peters, United States
Foundation Grants: Collaborative Scientist
Thomas Peters, United States
Foundation Grants: Collaborative Scientist
Thomas Peters, United States
Foundation Grants: Busuttil Scholarship
Thomas Peters, United States
Foundation Grants: Busuttil Scholarship
ASTS WTC 2025, United States
Industry Sponsored: Transmedics
ASTS WTC 2025, United States
Industry Sponsored: Transmedics
ASTS WTC 2025, United States
Industry Sponsored: Takeda
ASTS WTC 2025, United States
Industry Sponsored: Takeda
ASTS WTC 2025, United States
Industry Sponsored: Gift of Life
ASTS WTC 2025, United States
Industry Sponsored: Gift of Life
ASTS WTC 2025, United States
Industry Sponsored: Veloxis
ASTS WTC 2025, United States
Industry Sponsored: Veloxis
ASTS WTC 2025, United States
Jon Fryer Resident Scientist Scholarship
ASTS WTC 2025, United States
Jon Fryer Resident Scientist Scholarship
ASTS WTC 2025, United States
ATP Scholarship
ASTS WTC 2025, United States
ATP Scholarship
ASTS WTC 2025, United States
Presidential Student Mentorship
ASTS WTC 2025, United States
Presidential Student Mentorship
ASTS WTC 2025, United States
Member Grant Sponsor Video
ASTS WTC 2025, United States
Member Grant Sponsor Video
Thomas Peters, United States
Closing Statements and Presidential Intro
Thomas Peters, United States
Closing Statements and Presidential Intro
Ginny Bumgardner, United States
Pioneer Award
Ginny Bumgardner, United States
Pioneer Award
Christian Larsen, United States
Pioneer Award Recipient
Christian Larsen, United States
Pioneer Award Recipient
12:15-15:30 8
8
12:15
Invited Symposia: Long-Term Care of Pancreas Transplant Recipients: What Nephrologists Need to Know
Full Details
Neeraj Singh, United States
Weight Gain After Pancreas Transplantation
Neeraj Singh, United States
Weight Gain After Pancreas Transplantation
Meaghan Stumpf, United States
Type 2 DM / Hyperglycemia in Pancreas Recipients
Meaghan Stumpf, United States
Type 2 DM / Hyperglycemia in Pancreas Recipients
Aleksandra Kukla, United States
Alloimmunity: Rejection Monitoring and Treatment
Aleksandra Kukla, United States
Alloimmunity: Rejection Monitoring and Treatment
Swati Rao, United States
Reproductive Health: Contraception and Pregnancy After Pancreas Transplantation
Swati Rao, United States
Reproductive Health: Contraception and Pregnancy After Pancreas Transplantation
Henry Pleass, Australia
Late Surgical Complications
Henry Pleass, Australia
Late Surgical Complications
George Burke III, United States
Autoimmunity: Recurrence of Type 1 DM
George Burke III, United States
Autoimmunity: Recurrence of Type 1 DM
Ty Dunn, United States
Novel Immunosuppression in Pancreas Transplantation
Ty Dunn, United States
Novel Immunosuppression in Pancreas Transplantation
12:15-15:30 155
155
12:15
Invited Symposia: Clinical Tolerance - News and Updates on Ongoing Trials
Full Details
Joseph Leventhal, United States
Update of Ongoing Clinical Trials in Tolerance
Joseph Leventhal, United States
Update of Ongoing Clinical Trials in Tolerance
Joshua Weiner, United States
Use of Anti-CD2 in Tolerance - The PANORAMA Trial
Joshua Weiner, United States
Use of Anti-CD2 in Tolerance - The PANORAMA Trial
Sandy Feng, United States
Predictive Biomarkers in Tolerance
Sandy Feng, United States
Predictive Biomarkers in Tolerance
Rainer Oberbauer, Austria
Combining Treg With Bone Marrow Transplantation for Tolerance - TREX001
Rainer Oberbauer, Austria
Combining Treg With Bone Marrow Transplantation for Tolerance - TREX001
12:15-15:30 25
25
12:15
Invited Symposia: Healthcare Systems Under Stress: Transplantation in Times of Pandemics, War, and Climate Disasters
Full Details
Steven Wisel, United States
When Nature Strikes Back: Natural Disasters and Climate Change Impact of Transplant Centers
Steven Wisel, United States
When Nature Strikes Back: Natural Disasters and Climate Change Impact of Transplant Centers
Maddalena Giannella, Italy
Confronting a Pandemic: Lessons Learned From COVID-19
Maddalena Giannella, Italy
Confronting a Pandemic: Lessons Learned From COVID-19
Peter Chin-Hong, United States
Hot and Cold: How Climate Impacts Infectious Diseases
Peter Chin-Hong, United States
Hot and Cold: How Climate Impacts Infectious Diseases
12:15-15:30 20
20
12:15
Invited Symposia: Frailty in Thoracic Transplantation
Full Details
Lianne Singer, Canada
Defining and Assessing Frailty in Thoracic Transplant
Lianne Singer, Canada
Defining and Assessing Frailty in Thoracic Transplant
Laurie Snyder, United States
Hot Topic Debate - Should We Be Using Frailty to Make Decisions in Lung Transplant (CON)
Laurie Snyder, United States
Hot Topic Debate - Should We Be Using Frailty to Make Decisions in Lung Transplant (CON)
Sean Pinney, United States
Hot Topic Debate - Should We Be Using Frailty to Make Decisions in Heart Transplant (CON)
Sean Pinney, United States
Hot Topic Debate - Should We Be Using Frailty to Make Decisions in Heart Transplant (CON)
Brian Hsi, United States
Hot Topic Debate - Should We Be Using Frailty to Make Decisions in Heart Transplant (PRO)
Brian Hsi, United States
Hot Topic Debate - Should We Be Using Frailty to Make Decisions in Heart Transplant (PRO)
Michaela Anderson, United States
Hot Topic Debate - Should We Be Using Frailty to Make Decisions in Lung Transplant (PRO)
Michaela Anderson, United States
Hot Topic Debate - Should We Be Using Frailty to Make Decisions in Lung Transplant (PRO)
12:15-15:30 23
23
12:15
Invited Symposia: Kidney Paired Donation - State of the Art
Full Details
Dorry Segev, United States
KPD Programs Around the World - Common Elements for Success
Dorry Segev, United States
KPD Programs Around the World - Common Elements for Success
Gabriel Danovitch, United States
International KPD - Dos and Don’ts
Gabriel Danovitch, United States
International KPD - Dos and Don’ts
Garet Hil, United States
Maximizing the Donor Experience - Donor Safeguards / Cost Minimization
Garet Hil, United States
Maximizing the Donor Experience - Donor Safeguards / Cost Minimization
Cathi Murphey, United States
The Importance of a Strong Immunogenetics Lab Partner
Cathi Murphey, United States
The Importance of a Strong Immunogenetics Lab Partner
Toby Coates, Australia
Inclusion of Donors Who Are Not ABO or HLA Incompatible - NDADs and Compatible Pairs
Toby Coates, Australia
Inclusion of Donors Who Are Not ABO or HLA Incompatible - NDADs and Compatible Pairs
12:15-15:30 153
153
12:15
Invited Symposia: Clinical Trials – How Can We Reinvigorate Transplant Trials?
Full Details
Anil Chandraker, United States
Lessons from the Transplant Therapeutics Consortium
Anil Chandraker, United States
Lessons from the Transplant Therapeutics Consortium
Prabir Roy-Chaudhury, United States
The ASN Experience in Engaging with Regulators, Funding Bodies, and Industry
Prabir Roy-Chaudhury, United States
The ASN Experience in Engaging with Regulators, Funding Bodies, and Industry
Peter Heeger, United States
Successes and Failures in Advancing Transplant Research
Peter Heeger, United States
Successes and Failures in Advancing Transplant Research
Kristi Coldwell, Canada
Patient Engagement in Clinical Trials
Kristi Coldwell, Canada
Patient Engagement in Clinical Trials
12:15-15:30 11
11
12:15
Invited Symposia: Save My Kidneys! Management of Kidney Disease in Liver Transplant Recipients
Full Details
Hassan Ibrahim, United States
Beyond Serum Creatinine: Renal Function Measurement in LT Candidates and Recipients: Role of Cystatin C and Novel Biomarkers
Hassan Ibrahim, United States
Beyond Serum Creatinine: Renal Function Measurement in LT Candidates and Recipients: Role of Cystatin C and Novel Biomarkers
Florence Wong, Canada
Kidney or Not: Liver Transplantation in Patients With Acute Kidney Injury
Florence Wong, Canada
Kidney or Not: Liver Transplantation in Patients With Acute Kidney Injury
Hani Wadei, United States
Role of Immunosuppression and Other Strategies to Preserve Kidney Function in Liver Transplant Recipients
Hani Wadei, United States
Role of Immunosuppression and Other Strategies to Preserve Kidney Function in Liver Transplant Recipients
12:15-15:30 10
10
12:15
Invited Symposia: Cutaneous Malignancies in Solid Organ Transplantation: A New Era with Novel Agents
Full Details
Christopher Blosser, United States
Clinical Considerations for Initiating Immune Checkpoint Inhibitors in Cutaneous Malignancy Treatment Post-transplantation
Christopher Blosser, United States
Clinical Considerations for Initiating Immune Checkpoint Inhibitors in Cutaneous Malignancy Treatment Post-transplantation
Naoka Murakami, United States
Challenges in Managing Cutaneous Malignancy Post-transplant: Adjusting Maintenance Immunosuppression Strategies
Naoka Murakami, United States
Challenges in Managing Cutaneous Malignancy Post-transplant: Adjusting Maintenance Immunosuppression Strategies
Germaine Wong, Australia
Evaluating Recurrence Risk of Cutaneous Malignancies in Transplant Recipients: Implications for Candidacy Assessment
Germaine Wong, Australia
Evaluating Recurrence Risk of Cutaneous Malignancies in Transplant Recipients: Implications for Candidacy Assessment
Sarah Arron, United States
Risk of Cutaneous Malignancies in Transplant Recipients: Implications for Listing and Screening
Sarah Arron, United States
Risk of Cutaneous Malignancies in Transplant Recipients: Implications for Listing and Screening
12:15-15:30 24
24
12:15
Invited Symposia: The Global Need for Organ Replacement in 2030
Full Details
M Tonelli, Canada
Noncommunicable Disease Burden and Future Management Challenges- Diabetes and Kidney Disease
M Tonelli, Canada
Noncommunicable Disease Burden and Future Management Challenges- Diabetes and Kidney Disease
Jeffrey Teuteberg, United States
Heart Replacement Therapy
Jeffrey Teuteberg, United States
Heart Replacement Therapy
Benjamin Hippen, United States
Dialysis vs Transplant in Low Income Countries
Benjamin Hippen, United States
Dialysis vs Transplant in Low Income Countries
Nancy Ascher, United States
Liver Replacement Therapy
Nancy Ascher, United States
Liver Replacement Therapy
12:15-15:30 21
21
12:15
Invited Symposia: Updates in Liver Allocation: How Has Policy Impacted Practice in the US?
Full Details
Allison Kwong, United States
MELD 3.0 and the Potential for Continuous Distribution
Allison Kwong, United States
MELD 3.0 and the Potential for Continuous Distribution
Amit Mathur, United States
Expedited Liver Offers
Amit Mathur, United States
Expedited Liver Offers
Majella Doyle, United States
Allocation Updates Related to Transplant Oncology
Majella Doyle, United States
Allocation Updates Related to Transplant Oncology
12:15-15:30 22
22
12:15
Invited Symposia: Antibiosis and the Anastomosis: Surgical Considerations for Post-Transplant Infections
Full Details
Ankit Mittal, India
Global Perspective: Periop Antibacterial and Antifungal Prophylaxis in Liver Transplant
Ankit Mittal, India
Global Perspective: Periop Antibacterial and Antifungal Prophylaxis in Liver Transplant
Joseph Kim, Canada
Asymptomatic Bacteriuria in Kidney Transplant
Joseph Kim, Canada
Asymptomatic Bacteriuria in Kidney Transplant
Cameron Wolfe, United States
Addressing Donor Cultures in the Face of Preservation and Perfusion Technologies
Cameron Wolfe, United States
Addressing Donor Cultures in the Face of Preservation and Perfusion Technologies
12:15-15:15 9
9
12:15
Invited Symposia: Endothelial Cells
Full Details
Jordan Pober, United States
Targeting Endothelial Cell Il-15 Trans-Presentation
Jordan Pober, United States
Targeting Endothelial Cell Il-15 Trans-Presentation
Elaine F. Reed, United States
Endothelial Cell-Mediated Polarization of Macrophages
Elaine F. Reed, United States
Endothelial Cell-Mediated Polarization of Macrophages
Marion Rabant, France
Diagnostic Roles of Endothelial Cells During Antibody-Mediated Rejection
Marion Rabant, France
Diagnostic Roles of Endothelial Cells During Antibody-Mediated Rejection
12:15-15:15 12
12
12:15
Invited Symposia: EBV/PTLD: State-of-the-Art Consensus Update
Full Details
Olivia Martinez, United States
Biomarkers for PTLD
Olivia Martinez, United States
Biomarkers for PTLD
Michael Green, United States
IPTA Consensus Update
Michael Green, United States
IPTA Consensus Update
Thomas Gross, United States
Treatment of PTLD in 2025
Thomas Gross, United States
Treatment of PTLD in 2025
12:15-15:15 4
4
12:15
Invited Symposia: Beyond Just Survival: Addressing Transplant Recipients’ Perspective of Unmet Immunosuppressant Needs: The AST’s National Survey of 10,000 Transplant Recipients
Full Details
David Taber, United States
Survey Rationale, Design, and High-Level Findings
David Taber, United States
Survey Rationale, Design, and High-Level Findings
Roshan George, United States
Response Findings in Pediatrics - Similarities and Differences as Compared to Adults
Roshan George, United States
Response Findings in Pediatrics - Similarities and Differences as Compared to Adults
Larissa Myaskovsky, United States
Comparisons of Finding Across Kidney, Liver, Heart, Lung, Pancreas, Intestine, and VCA Recipients
Larissa Myaskovsky, United States
Comparisons of Finding Across Kidney, Liver, Heart, Lung, Pancreas, Intestine, and VCA Recipients
12:15-15:30 154
154
12:15
Invited Symposia: Women in Transplantation: Opportunities, Challenges, and Strategies for Advancement and Allyship
Full Details
Sarah Tsou, United States
Panelist
Sarah Tsou, United States
Panelist
Curie Ahn, Korea
Panelist
Curie Ahn, Korea
Panelist
Jasleen Kukreja, United States
Panelist
Jasleen Kukreja, United States
Panelist
Ligia Pierrotti, Brazil
Panelist
Ligia Pierrotti, Brazil
Panelist
16:30-17:30 153
153
16:30
Rapid Fire Oral Abstract Session: Kidney Transplant Cardiometabolic Risk Assessment and Outcomes
Full Details
Yusi Chen, United States
GLP-1 Receptor Agonists: Advancing Kidney Transplant Access and Safety in a National ESKD Cohort
Yusi Chen, United States
GLP-1 Receptor Agonists: Advancing Kidney Transplant Access and Safety in a National ESKD Cohort
Diana Rodríguez-Espinosa, Spain
SGLT2 Inhbitors Reduce the eGFR Slope in Diabetic and Non-Diabetic Kidney Transplant Recipients
Diana Rodríguez-Espinosa, Spain
SGLT2 Inhbitors Reduce the eGFR Slope in Diabetic and Non-Diabetic Kidney Transplant Recipients
Dhiren Kumar, United States
Incorporating Six-Minute Walk Test, Cardio-Pulmonary Exercise Testing and Renal Rehabilitation in Kidney Transplant Candidates: A Descriptive Report
Dhiren Kumar, United States
Incorporating Six-Minute Walk Test, Cardio-Pulmonary Exercise Testing and Renal Rehabilitation in Kidney Transplant Candidates: A Descriptive Report
Steve Chadban, Australia
Distinct Differences in the Pattern of Major Adverse Cardiac Events Pre- and Post-Kidney Transplantation: The CARSK Study
Steve Chadban, Australia
Distinct Differences in the Pattern of Major Adverse Cardiac Events Pre- and Post-Kidney Transplantation: The CARSK Study
Zalan Shah, United States
Left Ventricular Global Longitudinal Strain Predicts Major Adverse Cardiac Events in Kidney Transplant Recipients
Zalan Shah, United States
Left Ventricular Global Longitudinal Strain Predicts Major Adverse Cardiac Events in Kidney Transplant Recipients
Malika Wilson, United States
The Hidden Threat: Air Pollution Harming Cardiovascular and Cognitive Health in Older Kidney Transplant Recipients
Malika Wilson, United States
The Hidden Threat: Air Pollution Harming Cardiovascular and Cognitive Health in Older Kidney Transplant Recipients
Anshul Bhalla, United States
Evidence-Based Population Health Management Program for Diabetes Mellitus Type 2 Management in Kidney Transplant Recipients
Anshul Bhalla, United States
Evidence-Based Population Health Management Program for Diabetes Mellitus Type 2 Management in Kidney Transplant Recipients
Eric Stein, United States
Electrocardiographic Predictors of Major Adverse Cardiovascular Events in Renal Transplant Recipients
Eric Stein, United States
Electrocardiographic Predictors of Major Adverse Cardiovascular Events in Renal Transplant Recipients
16:30-17:45 24
24
16:30
Oral Abstract: Normothermic Machine Perfusion in Clinical Use
Full Details
Charles Strom, United States
Implementation of an OPO-Driven NRP Program: Impact on Abdominal Organ Utilization
Charles Strom, United States
Implementation of an OPO-Driven NRP Program: Impact on Abdominal Organ Utilization
Jean Lee, United States
Initial Experience in a Porcine Autotransplantation Model to Validate Normothermic Ex Vivo Kidney Perfusion
Jean Lee, United States
Initial Experience in a Porcine Autotransplantation Model to Validate Normothermic Ex Vivo Kidney Perfusion
Leonie van Leeuwen, United States
Reducing Kidney Discard: Do NMP Parameters Correlate with Post-Transplant Graft Function?
Leonie van Leeuwen, United States
Reducing Kidney Discard: Do NMP Parameters Correlate with Post-Transplant Graft Function?
Jake Miles, United States
Largest Real-World Multi-Center Study Outcomes Reported with Controlled Moderate Hypothermic Preservation of Donor Livers
Jake Miles, United States
Largest Real-World Multi-Center Study Outcomes Reported with Controlled Moderate Hypothermic Preservation of Donor Livers
Braxton Goodnight, United States
Donor Liver Weight in Normothermic Ex Situ Machine Perfusion: Do Large Livers Perform Worse?
Braxton Goodnight, United States
Donor Liver Weight in Normothermic Ex Situ Machine Perfusion: Do Large Livers Perform Worse?
Anastasia Xynogala, United States
Normothermic Regional Perfusion (NRP) Combined with Hypothermic Oxygenated Machine Perfusion (HMP-O2) Reduces Oxygen Deficit during Preservation in DCD Liver Allografts
Anastasia Xynogala, United States
Normothermic Regional Perfusion (NRP) Combined with Hypothermic Oxygenated Machine Perfusion (HMP-O2) Reduces Oxygen Deficit during Preservation in DCD Liver Allografts
Avery Fortier, United States
Secondary Perfusion: Modeling Viability of Organs Declined for Transplant
Avery Fortier, United States
Secondary Perfusion: Modeling Viability of Organs Declined for Transplant
16:30-17:45 12
12
16:30
Oral Abstract: Basic Mechanisms of Rejection
Full Details
John Pell, United States
A T Cell Intrinsic Role for APOL1 Risk Alleles in Allograft Rejection
John Pell, United States
A T Cell Intrinsic Role for APOL1 Risk Alleles in Allograft Rejection
Khodor Abou-Daya, United States
Ebp1 is Required for Maintenance of CD8+ TRM in Transplant Rejection
Khodor Abou-Daya, United States
Ebp1 is Required for Maintenance of CD8+ TRM in Transplant Rejection
Nadim AL RAHY, United States
Discovery of a Novel Role of CD74 in Alloimmunity through Binding and Stabilizing IFNƔ Receptor on T Cells
Nadim AL RAHY, United States
Discovery of a Novel Role of CD74 in Alloimmunity through Binding and Stabilizing IFNƔ Receptor on T Cells
Jianye Cai, United States
Modulating Crosstalk Between Macrophages and Renal Tubular Epithelial Cells Improves Kidney Transplant Outcome
Jianye Cai, United States
Modulating Crosstalk Between Macrophages and Renal Tubular Epithelial Cells Improves Kidney Transplant Outcome
SHU LI, United States
Allorecognition and Costimulation of Human Endothelium-Derived Extracellular Vesicles in Initiating Allo-Specific CD4 Cell Immune Responses
SHU LI, United States
Allorecognition and Costimulation of Human Endothelium-Derived Extracellular Vesicles in Initiating Allo-Specific CD4 Cell Immune Responses
David Hildeman, United States
Leveraging Heterologous Immunity to Provide Insights into Alloreactivity
David Hildeman, United States
Leveraging Heterologous Immunity to Provide Insights into Alloreactivity
Grace Zhou, United States
Mapping Immunodominant Indirect CD4+ T Cell Epitopes Associated with Transplant Rejection
Grace Zhou, United States
Mapping Immunodominant Indirect CD4+ T Cell Epitopes Associated with Transplant Rejection
Dan Jane-wit, United States
Intracellular Membrane Attack Complexes Disrupt Proteostasis and Acquire Alarmin-Like Properties during Antibody-Mediated Rejection
Dan Jane-wit, United States
Intracellular Membrane Attack Complexes Disrupt Proteostasis and Acquire Alarmin-Like Properties during Antibody-Mediated Rejection
16:30-17:45 21
21
16:30
Oral Abstract: Viral Frontlines: Tracking Vaccine-Preventable Viruses
Full Details
German Contreras, United States
Risk of RSV Infection in Solid Organ Transplant Recipients: A Real-World, Propensity Score-Matched Analysis of RSV Vaccination
German Contreras, United States
Risk of RSV Infection in Solid Organ Transplant Recipients: A Real-World, Propensity Score-Matched Analysis of RSV Vaccination
Chia-Yu Chiu, United States
Seroprevalence and Incidence of Measles, Mumps, and Rubella in Adult Solid Organ Transplant Recipients: A Large Database Analysis
Chia-Yu Chiu, United States
Seroprevalence and Incidence of Measles, Mumps, and Rubella in Adult Solid Organ Transplant Recipients: A Large Database Analysis
Victoria Hall, Canada
International Multicenter Study of the Outcomes of Infection with Neglected Respiratory Viruses in Solid Organ Transplant Recipients
Victoria Hall, Canada
International Multicenter Study of the Outcomes of Infection with Neglected Respiratory Viruses in Solid Organ Transplant Recipients
Andrew Karaba, United States
Durability of RSV Antibodies Following RSV Vaccination in Solid Organ Transplant Recipients
Andrew Karaba, United States
Durability of RSV Antibodies Following RSV Vaccination in Solid Organ Transplant Recipients
Helen Pizzo, United States
Risk Factors for Loss of Varicella Immunity After Pediatric Kidney Transplantation
Helen Pizzo, United States
Risk Factors for Loss of Varicella Immunity After Pediatric Kidney Transplantation
José Pestana, Brazil
Early and Long-Term COVID-19 Outcomes in Pediatric Kidney Transplant Recipients: Results from a Brazilian Multicenter Study
José Pestana, Brazil
Early and Long-Term COVID-19 Outcomes in Pediatric Kidney Transplant Recipients: Results from a Brazilian Multicenter Study
Avery Koi, United States
One-Year Thromboembolic Outcomes in COVID-19+ Solid Organ Transplant Recipients: Comparing Triple-Vaccinated vs. Unvaccinated Patients
Avery Koi, United States
One-Year Thromboembolic Outcomes in COVID-19+ Solid Organ Transplant Recipients: Comparing Triple-Vaccinated vs. Unvaccinated Patients
Lisa Coscia, United States
COVID-19 Infection during Pregnancy in Transplant Recipients
Lisa Coscia, United States
COVID-19 Infection during Pregnancy in Transplant Recipients
16:30-17:45 11
11
16:30
Oral Abstract: Transplant Administration and Quality
Full Details
Grace Lyden, United States
Historical Priors for Bayesian Assessment of Transplant Program Performance
Grace Lyden, United States
Historical Priors for Bayesian Assessment of Transplant Program Performance
Amber Paulus, United States
Optimizing Readmission Risk Thresholds for Remote Patient Monitoring of Kidney Transplant Recipients A Cost-Benefit Analysis
Amber Paulus, United States
Optimizing Readmission Risk Thresholds for Remote Patient Monitoring of Kidney Transplant Recipients A Cost-Benefit Analysis
Vikram Raghu, United States
Impact of Current MPSC Program Metrics on Pediatric Solid Organ Transplant Programs
Vikram Raghu, United States
Impact of Current MPSC Program Metrics on Pediatric Solid Organ Transplant Programs
Krista Lentine, United States
Contemporary Practice and Challenges in Managing the Costs of Kidney Paired Donation: A Survey of US Transplant Professionals
Krista Lentine, United States
Contemporary Practice and Challenges in Managing the Costs of Kidney Paired Donation: A Survey of US Transplant Professionals
Nino Dzebisashvili, United States
Impact of Protocol AlloSure on Resource Utilization in Kidney Transplantation
Nino Dzebisashvili, United States
Impact of Protocol AlloSure on Resource Utilization in Kidney Transplantation
Mustafa Nazzal, United States
Changing Dynamics in Liver Allocation: Donor and Recipient Traits Pre- and Post Acuity Circle Implementation
Mustafa Nazzal, United States
Changing Dynamics in Liver Allocation: Donor and Recipient Traits Pre- and Post Acuity Circle Implementation
Cinthia Lozano, United States
Survival After Listing, a New Metric to Provide Patients with Comparative Information About Patient Experience Across Transplant Centers
Cinthia Lozano, United States
Survival After Listing, a New Metric to Provide Patients with Comparative Information About Patient Experience Across Transplant Centers
Alexandra Strauss, United States
Assessment of Process Variation in Liver, Kidney, and Pancreas Transplantation Using the Consortium for the Holistic Assessment of Risk in Transplant (CHART)
Alexandra Strauss, United States
Assessment of Process Variation in Liver, Kidney, and Pancreas Transplantation Using the Consortium for the Holistic Assessment of Risk in Transplant (CHART)
16:30-17:45 22
22
16:30
Oral Abstract: Intestinal Transplantation and Rehabilitation
Full Details
Carolyn Smullin, United States
The Discarded Donor Intestine: A Review of Donor Criteria, Donor Availability and Usage, and Current Efforts to Expand Donor Access
Carolyn Smullin, United States
The Discarded Donor Intestine: A Review of Donor Criteria, Donor Availability and Usage, and Current Efforts to Expand Donor Access
Mohamed Khalaf, United States
Rituximab Induction Therapy in Intestinal Transplantation: Beneficial Effects on De Novo DSA Development
Mohamed Khalaf, United States
Rituximab Induction Therapy in Intestinal Transplantation: Beneficial Effects on De Novo DSA Development
Liara Gonzalez, United States
Normothermic Machine Perfusion Mitigates Allograft Inflammation in Intestinal Transplantation
Liara Gonzalez, United States
Normothermic Machine Perfusion Mitigates Allograft Inflammation in Intestinal Transplantation
Julie Hong, United States
Reconsidering the Immune Pathway of Intestinal Transplant Rejection: Novel Insights from Comparison with Crohn’s Disease
Julie Hong, United States
Reconsidering the Immune Pathway of Intestinal Transplant Rejection: Novel Insights from Comparison with Crohn’s Disease
Yuqi Dong, People's Republic of China
Establishment of a Large Animal Model for Ischemia-Free Intestine Transplantation
Yuqi Dong, People's Republic of China
Establishment of a Large Animal Model for Ischemia-Free Intestine Transplantation
Yohei Yamada, Japan
Donor-Derived Cell-Free DNA Analyses in Small Intestine Transplantation: A Multicenter Prospective Observational Study in Japan
Yohei Yamada, Japan
Donor-Derived Cell-Free DNA Analyses in Small Intestine Transplantation: A Multicenter Prospective Observational Study in Japan
Michael Gianarakis, United States
Multivisceral versus Isolated Intestinal Transplantation: A Comparative Analysis of Morbidity, Mortality, and Graft-Related Outcomes
Michael Gianarakis, United States
Multivisceral versus Isolated Intestinal Transplantation: A Comparative Analysis of Morbidity, Mortality, and Graft-Related Outcomes
16:30-17:45 10
10
16:30
Oral Abstract: Reduced Sized Grafts, Living and Deceased Livers
Full Details
Amar Gupta, United States
Robotic Donor Right Hepatectomy is a Safe Operation with a Short Learning Curve: 50 Consecutive Cases from a Single North American Center
Amar Gupta, United States
Robotic Donor Right Hepatectomy is a Safe Operation with a Short Learning Curve: 50 Consecutive Cases from a Single North American Center
Vikraman Vikraman Gunabushanam, United States
Over One Thousand Consecutive Living Donor Hepatectomies over 24 Years at a Single Institution- The Impact of ERAS Protocols on Donor Recovery
Vikraman Vikraman Gunabushanam, United States
Over One Thousand Consecutive Living Donor Hepatectomies over 24 Years at a Single Institution- The Impact of ERAS Protocols on Donor Recovery
Deok-Gie Kim, Korea
QUALITY Score, Development of Integrative Prognostic Index for Living Donor Liver Using Multicentric Registry Data
Deok-Gie Kim, Korea
QUALITY Score, Development of Integrative Prognostic Index for Living Donor Liver Using Multicentric Registry Data
Takeo Toshima, Japan
Refining the Prognostic Framework for Small-for-Size Graft Syndrome Grade B After LDLT: A Multicenter Study by the iLDLT Group
Takeo Toshima, Japan
Refining the Prognostic Framework for Small-for-Size Graft Syndrome Grade B After LDLT: A Multicenter Study by the iLDLT Group
Shinichiro Yokota, United States
Shifting Landscape of Adult Liver Transplantation in the United States: Declining Role of Living Donor Transplants?
Shinichiro Yokota, United States
Shifting Landscape of Adult Liver Transplantation in the United States: Declining Role of Living Donor Transplants?
Jessica Singh, Germany
reduced sized grafts, living and deceased livers
Jessica Singh, Germany
reduced sized grafts, living and deceased livers
Siyuan Yao, United States
Graft-to-Spleen Volume Ratio is a New Indicator for Splenectomy in Living Donor Liver Transplantation to Protect Graft Function: Retrospective Analysis and Prospective Validation
Siyuan Yao, United States
Graft-to-Spleen Volume Ratio is a New Indicator for Splenectomy in Living Donor Liver Transplantation to Protect Graft Function: Retrospective Analysis and Prospective Validation
Yu Minami, Japan
Feasibility and Outcomes of Living-Donor Liver Transplantation in Elderly Patients Aged 70 Years and Older: A Propensity Score-Matched Analysis
Yu Minami, Japan
Feasibility and Outcomes of Living-Donor Liver Transplantation in Elderly Patients Aged 70 Years and Older: A Propensity Score-Matched Analysis
16:30-17:45 9
9
16:30
Oral Abstract: International Perspectives on Public Policy
Full Details
Antonia Cronin, United Kingdom
Exploring Public Attitudes and Views on Xenotransplantation: Results from the First Representative United Kingdom Sample Survey
Antonia Cronin, United Kingdom
Exploring Public Attitudes and Views on Xenotransplantation: Results from the First Representative United Kingdom Sample Survey
Gordon Treacy, Ireland
Kidney Transplantation: Are There Differences in Kidney Donation and Transplantation Rates When Countries Switch from an Opt-In to and Opt-Out System?
Gordon Treacy, Ireland
Kidney Transplantation: Are There Differences in Kidney Donation and Transplantation Rates When Countries Switch from an Opt-In to and Opt-Out System?
Fatima Malik, United Kingdom
Association Between Socio-Economic Factors and Kidney Transplantation Activity Across Muslim Majority Countries
Fatima Malik, United Kingdom
Association Between Socio-Economic Factors and Kidney Transplantation Activity Across Muslim Majority Countries
John Yang, Korea
About Time: Improving Equity in Korean Kidney Allocation System through Virtual Crossmatch
John Yang, Korea
About Time: Improving Equity in Korean Kidney Allocation System through Virtual Crossmatch
Chase Wehrle, United States
The Growth and Development of Liver Transplantation in the United Arab Emirates
Chase Wehrle, United States
The Growth and Development of Liver Transplantation in the United Arab Emirates
Angelika Rzepka, Austria
Enhancing Post-Transplant Care in Austria: A Survey of Primary Care Physicians' Needs and the Potential for Integrated Care Software
Angelika Rzepka, Austria
Enhancing Post-Transplant Care in Austria: A Survey of Primary Care Physicians' Needs and the Potential for Integrated Care Software
Reg Green, United States
The Boy Who Saved Thousands of Lives
Reg Green, United States
The Boy Who Saved Thousands of Lives
Adnan Sharif, United Kingdom
Teaching of Organ Donation is Sub-Optimal in English High Schools
Adnan Sharif, United Kingdom
Teaching of Organ Donation is Sub-Optimal in English High Schools
16:30-17:45 4
4
16:30
Oral Abstract: Deceased Donor Kidney Allocation
Full Details
Maria Masotti, United States
The Additional Dialysis Time That Would Eliminate the Posttransplant Survival Benefit of a Better Kidney Offer
Maria Masotti, United States
The Additional Dialysis Time That Would Eliminate the Posttransplant Survival Benefit of a Better Kidney Offer
Matthew Kadatz, Canada
Association Between Geographic Variation in Kidney Transplant Wait Times and Utilization of Deceased Donor Kidneys in the U.S.
Matthew Kadatz, Canada
Association Between Geographic Variation in Kidney Transplant Wait Times and Utilization of Deceased Donor Kidneys in the U.S.
Justin Weissberg, United States
The Shift to Acuity Circles: Analyzing Changes in Kidney Transplant Access Across Socioeconomic and Geographic Lines
Justin Weissberg, United States
The Shift to Acuity Circles: Analyzing Changes in Kidney Transplant Access Across Socioeconomic and Geographic Lines
Loren Gragert, United States
A Novel Strategy for Prioritizing Closer HLA Matching in Kidney Allocation Policy Would Avoid a Tradeoff of Increased Ethnic Disparity
Loren Gragert, United States
A Novel Strategy for Prioritizing Closer HLA Matching in Kidney Allocation Policy Would Avoid a Tradeoff of Increased Ethnic Disparity
Anne Huml, United States
Outcomes of Deceased Donor Kidney Transplants Allocated out of Sequence in the United States
Anne Huml, United States
Outcomes of Deceased Donor Kidney Transplants Allocated out of Sequence in the United States
Rajalingam Raja, United States
Virtual Crossmatch Outcomes Support Using OPTN Match Run as the Final Crossmatch to Improve Kidney Allocation Efficiency
Rajalingam Raja, United States
Virtual Crossmatch Outcomes Support Using OPTN Match Run as the Final Crossmatch to Improve Kidney Allocation Efficiency
Kate Wyburn, Australia
Prognosis Matching in the Australian Deceased Donor Kidney Allocation Algorithm
Kate Wyburn, Australia
Prognosis Matching in the Australian Deceased Donor Kidney Allocation Algorithm
Teresa Po-Yu Chiang, United States
The Rapidly Shifting Calibration Between KDRI, KDPI, and Graft Survival: It’s Time to Stop Moving the Goalposts!
Teresa Po-Yu Chiang, United States
The Rapidly Shifting Calibration Between KDRI, KDPI, and Graft Survival: It’s Time to Stop Moving the Goalposts!
16:30-17:45 8
8
16:30
Oral Abstract: Kidney Novel Immune Risk Assessment and Monitoring
Full Details
Friederike Martin, United States
Historically Reported Donor Specific Antibodies Rather Than Current Should Be Used to Assess Immunological Risk After Kidney Transplant (KTx)
Friederike Martin, United States
Historically Reported Donor Specific Antibodies Rather Than Current Should Be Used to Assess Immunological Risk After Kidney Transplant (KTx)
Dhiren Kumar, United States
The Role of Molecular Microscope and Donor Derived Cell Free DNA to Guide Therapy for T-Cell Mediated Rejection in Kidney Transplants
Dhiren Kumar, United States
The Role of Molecular Microscope and Donor Derived Cell Free DNA to Guide Therapy for T-Cell Mediated Rejection in Kidney Transplants
Jiqiu Wen, People's Republic of China
Diffusion Kurtosis Imaging Biomarkers Stratify Graft Injury and T Cell-Mediated Rejection in Renal Transplantation: A Multimodal Approach
Jiqiu Wen, People's Republic of China
Diffusion Kurtosis Imaging Biomarkers Stratify Graft Injury and T Cell-Mediated Rejection in Renal Transplantation: A Multimodal Approach
Yong Chul Kim, Korea
Discovering Molecular Signatures in ATMR: Single-Cell RNA-Sequencing Analysis of Human Blood and Tissue Spatial Transcriptomics
Yong Chul Kim, Korea
Discovering Molecular Signatures in ATMR: Single-Cell RNA-Sequencing Analysis of Human Blood and Tissue Spatial Transcriptomics
Minnie Sarwal, United States
Transcriptomic Insights into HIV Rejection Profiles in Renal Transplant Recipients
Minnie Sarwal, United States
Transcriptomic Insights into HIV Rejection Profiles in Renal Transplant Recipients
Nida Saleem, Australia
PIRCHE-II Scores Correlate with Early Transcriptional Changes in Kidney Transplant Recipients with Antibody Mediated Rejection
Nida Saleem, Australia
PIRCHE-II Scores Correlate with Early Transcriptional Changes in Kidney Transplant Recipients with Antibody Mediated Rejection
Caroline Jadlowiec, United States
Evaluating the Role of Molecular Mismatches in Kidney Graft Survival Using the PIRCHE-II and SNOW Algorithms: A Study from Mayo Clinic
Caroline Jadlowiec, United States
Evaluating the Role of Molecular Mismatches in Kidney Graft Survival Using the PIRCHE-II and SNOW Algorithms: A Study from Mayo Clinic
Jenny Tran, Canada
HLA Eplet (HLAMatchmaker) and T Cell Epitope (PIRCHE) Mismatch and the Risk of Acute Rejection in Kidney Transplant Recipients
Jenny Tran, Canada
HLA Eplet (HLAMatchmaker) and T Cell Epitope (PIRCHE) Mismatch and the Risk of Acute Rejection in Kidney Transplant Recipients
16:30-17:45 23
23
16:30
Oral Abstract: Living Donor Kidney Public Awareness and Access
Full Details
Justin Weissberg, United States
Bridging the Gap: How Geography and Socioeconomic Factors Shape Access to Living Donor Kidney Transplant
Justin Weissberg, United States
Bridging the Gap: How Geography and Socioeconomic Factors Shape Access to Living Donor Kidney Transplant
Douglas Keith, United States
Are Changing Demographics of Candidates for Kidney Transplant the Reason for Lack of Growth in Living Donor Transplant in the United States?
Douglas Keith, United States
Are Changing Demographics of Candidates for Kidney Transplant the Reason for Lack of Growth in Living Donor Transplant in the United States?
Rose Scarlato, Australia
Living Donor Demographics in Australia and New Zealand: Have Disparities Increased over Time?
Rose Scarlato, Australia
Living Donor Demographics in Australia and New Zealand: Have Disparities Increased over Time?
Amit Tevar, United States
Impact of a Living Donor Coach on Living Donor Engagement and Racial Disparities in Kidney Transplantation
Amit Tevar, United States
Impact of a Living Donor Coach on Living Donor Engagement and Racial Disparities in Kidney Transplantation
Rajesh Anumolu, United States
Social Media & Organ Donation: Mapping Attitudes and Engagement
Rajesh Anumolu, United States
Social Media & Organ Donation: Mapping Attitudes and Engagement
Amy Waterman, United States
Effectiveness of a US Media Campaign Targeting the General Public to Increase Pursuit of Living Donation
Amy Waterman, United States
Effectiveness of a US Media Campaign Targeting the General Public to Increase Pursuit of Living Donation
Sierra Auleta, United States
Potential Living Kidney Donors' Preferences on Who Should Decide Donor Eligibility: Changes over Time
Sierra Auleta, United States
Potential Living Kidney Donors' Preferences on Who Should Decide Donor Eligibility: Changes over Time
Tariq Ali, Saudi Arabia
Low Risk HLAi (LRHLAi) Matching for Highly Sensitized Patients (HSP): A Successful KPD Matching Strategy
Tariq Ali, Saudi Arabia
Low Risk HLAi (LRHLAi) Matching for Highly Sensitized Patients (HSP): A Successful KPD Matching Strategy
16:30-17:45 25
25
16:30
Oral Abstract: Kidney Rejection
Full Details
Kai Castrezana Lopez, Switzerland
Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation: The Role of Biopsy-Based Transcript Diagnostics in Differentiating Immune Accommodation from Alloimmune Injury
Kai Castrezana Lopez, Switzerland
Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation: The Role of Biopsy-Based Transcript Diagnostics in Differentiating Immune Accommodation from Alloimmune Injury
Jenny Tran, Canada
HLA T Cell Epitope Mismatch and the Risk of Acute Rejection Among Participants in the Astellas Double Blind Randomized Early Corticosteroid Cessation Trial
Jenny Tran, Canada
HLA T Cell Epitope Mismatch and the Risk of Acute Rejection Among Participants in the Astellas Double Blind Randomized Early Corticosteroid Cessation Trial
Johan Noble, France
Tocilizumab Stabilizes Kidney Function and Reduce DSA in Kidney Transplant Recipients with Chronic Active Antibody-Mediated Rejection
Johan Noble, France
Tocilizumab Stabilizes Kidney Function and Reduce DSA in Kidney Transplant Recipients with Chronic Active Antibody-Mediated Rejection
Shana Coley, United States
Predicting Treatment Resistance at the Time of Diagnosis of Acute T Cell Mediated Rejection
Shana Coley, United States
Predicting Treatment Resistance at the Time of Diagnosis of Acute T Cell Mediated Rejection
Aylin Akifova, Germany
Combining PIRCHE-II and dd-cfDNA for Rejection Monitoring in Kidney Transplantation
Aylin Akifova, Germany
Combining PIRCHE-II and dd-cfDNA for Rejection Monitoring in Kidney Transplantation
Kai Castrezana Lopez, Switzerland
Non-HLA Autoantibodies - Anti-Angiotensin II Type 1 Receptor and Endothelin Type A Receptor Antibodies in the Diagnosis of Antibody-Mediated Rejection: Biopsy-Based Transcript Diagnostics Perspective
Kai Castrezana Lopez, Switzerland
Non-HLA Autoantibodies - Anti-Angiotensin II Type 1 Receptor and Endothelin Type A Receptor Antibodies in the Diagnosis of Antibody-Mediated Rejection: Biopsy-Based Transcript Diagnostics Perspective
Kofi Atiemo, United States
The Effect of United States Citizenship Status on Black Deceased Donor Kidney Transplant Outcomes
Kofi Atiemo, United States
The Effect of United States Citizenship Status on Black Deceased Donor Kidney Transplant Outcomes
Merih Gizlenci, United States
Depletion of Senescent Cells Prevents CNI-Induced Nephrotoxicity
Merih Gizlenci, United States
Depletion of Senescent Cells Prevents CNI-Induced Nephrotoxicity
16:30-17:45 154
154
16:30
Oral Abstract: Advances in Pediatric Kidney Transplant
Full Details
Kelley Hitchman, United States
Flow Cytometric Crossmatch for Pre-Transplant Immunologic Risk Assessment in Pediatric Kidney Transplant: STILL Not Necessary in Most Cases
Kelley Hitchman, United States
Flow Cytometric Crossmatch for Pre-Transplant Immunologic Risk Assessment in Pediatric Kidney Transplant: STILL Not Necessary in Most Cases
Qian Guo, United States
Large Scale Urinary Metabolomic Screening in the Prospective Multicenter VIRTUUS Children's Study
Qian Guo, United States
Large Scale Urinary Metabolomic Screening in the Prospective Multicenter VIRTUUS Children's Study
Meghan Pearl, United States
Antibodies to Angiotensin II Type 1 Receptor and Endothelin Type A Receptor in the First Year Post-Transplant Are Associated with Decline in Renal Function and HLA Donor Specific Antibodies at 5 Years Post-Transplant in Pediatric Kidney Transplant Recipients
Meghan Pearl, United States
Antibodies to Angiotensin II Type 1 Receptor and Endothelin Type A Receptor in the First Year Post-Transplant Are Associated with Decline in Renal Function and HLA Donor Specific Antibodies at 5 Years Post-Transplant in Pediatric Kidney Transplant Recipients
Clarkson Crane, United States
Tissue-Based Gene Expression Resolves Ambiguity When Histology is Indeterminant in Pediatric Kidney Transplant Recipients
Clarkson Crane, United States
Tissue-Based Gene Expression Resolves Ambiguity When Histology is Indeterminant in Pediatric Kidney Transplant Recipients
Ruby Patel, United States
Alternative, Low-Cost Monitoring of CD3 Cell Depletion Following Anti-Thymocyte Globulin Induction in Pediatric Renal Transplant Recipients
Ruby Patel, United States
Alternative, Low-Cost Monitoring of CD3 Cell Depletion Following Anti-Thymocyte Globulin Induction in Pediatric Renal Transplant Recipients
Dante Puntiel, United States
What is the Immunological Risk Threshold for Steroid-Free Immunosuppression in Pediatric Kidney Transplantation?
Dante Puntiel, United States
What is the Immunological Risk Threshold for Steroid-Free Immunosuppression in Pediatric Kidney Transplantation?
Stella Kilduff, United States
Impact of Living Donor Age and Sex on Pediatric Kidney Transplant Outcomes
Stella Kilduff, United States
Impact of Living Donor Age and Sex on Pediatric Kidney Transplant Outcomes
Michael Seifert, United States
Challenges in Non-Invasive Biomarker Profiling of Subclinical Borderline Rejection in Pediatric Kidney Transplantation
Michael Seifert, United States
Challenges in Non-Invasive Biomarker Profiling of Subclinical Borderline Rejection in Pediatric Kidney Transplantation
16:30-17:45 20
20
16:30
Late-Breaking Oral Abstract: Basic Science Advances in Transplantation: From T Cells to Tolerance
Full Details
Wai Yen Yim, People's Republic of China
First Evidence of Operational Tolerance in a Rare Case of Pediatric Heart Transplantation
Wai Yen Yim, People's Republic of China
First Evidence of Operational Tolerance in a Rare Case of Pediatric Heart Transplantation
Hong Xu, United States
Third-Party Haploidentical Bone Marrow Transplantation for the Induction of Transplant Tolerance
Hong Xu, United States
Third-Party Haploidentical Bone Marrow Transplantation for the Induction of Transplant Tolerance
Shane Walters, United States
Transcription Factor Aiolos Deficiency in CD8+ T Cells Impacts the Development and Cytotoxic Effector Function of Antibody Suppressor CD8+ T Cells
Shane Walters, United States
Transcription Factor Aiolos Deficiency in CD8+ T Cells Impacts the Development and Cytotoxic Effector Function of Antibody Suppressor CD8+ T Cells
Hong Xu, United States
JAK/STAT Pathway Inhibition Facilitates Mixed Chimerism with Reduced Conditioning for Allograft Tolerance
Hong Xu, United States
JAK/STAT Pathway Inhibition Facilitates Mixed Chimerism with Reduced Conditioning for Allograft Tolerance
Joshua Weiner, United States
Generation of Viable, Immunologically Distinct Intra-Species Chimeric Swine: Potential Implications for Novel Mechanisms of Tolerance
Joshua Weiner, United States
Generation of Viable, Immunologically Distinct Intra-Species Chimeric Swine: Potential Implications for Novel Mechanisms of Tolerance
Wyeth Alexander, United States
Load-Independent Assessment of Ex Situ Donor Hearts to Determine Transplant Suitability
Wyeth Alexander, United States
Load-Independent Assessment of Ex Situ Donor Hearts to Determine Transplant Suitability
Azita Mellati, United Kingdom
Necroptosis Inhibition in Kidney Ischaemia Reperfusion Injury- a Preclinical Study
Azita Mellati, United Kingdom
Necroptosis Inhibition in Kidney Ischaemia Reperfusion Injury- a Preclinical Study
zhengtao liu, People's Republic of China
Deciphering the Molecular Crosstalk Between Ferroptosis and Peroxisomes in Macrosteatotic Graft Failure Following Liver Transplantation: A Multi-Omics Perspective
zhengtao liu, People's Republic of China
Deciphering the Molecular Crosstalk Between Ferroptosis and Peroxisomes in Macrosteatotic Graft Failure Following Liver Transplantation: A Multi-Omics Perspective
16:30-17:45 155
155
16:30
Late-Breaking Oral Abstract: Late Breaking Studies in Transplant Infectious Diseases
Full Details
David Goldberg, United States
HCV Cure Rates in the THINKER-NEXT Trial of Transplanting Kidneys from HCV-Infected Donors into HCV-Negative Recipients
David Goldberg, United States
HCV Cure Rates in the THINKER-NEXT Trial of Transplanting Kidneys from HCV-Infected Donors into HCV-Negative Recipients
Victoria Hall, Canada
Adjuvanted Respiratory Syncytial Virus (RSV) Vaccination in High-risk Transplant Recipients
Victoria Hall, Canada
Adjuvanted Respiratory Syncytial Virus (RSV) Vaccination in High-risk Transplant Recipients
Nadiesda Costa, United States
Potravitug for the Treatment of BK Polyomavirus Infection in Kidney Transplant Recipients: a Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Nadiesda Costa, United States
Potravitug for the Treatment of BK Polyomavirus Infection in Kidney Transplant Recipients: a Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Hans Hirsch, Switzerland
Developing CD8 T cell mRNA Vaccines Targeting BK Polyomavirus Large T Antigen
Hans Hirsch, Switzerland
Developing CD8 T cell mRNA Vaccines Targeting BK Polyomavirus Large T Antigen
Anne Dipchand, Canada
Early experience with MMR vaccination in pediatric heart transplant recipients
Anne Dipchand, Canada
Early experience with MMR vaccination in pediatric heart transplant recipients
Rakesh Sindhi, United States
Cytomegalovirus-specific CD40LG-expressing T-cells are present before transplantation in CMV-seronegative recipients and predict early CMV DNAemia.
Rakesh Sindhi, United States
Cytomegalovirus-specific CD40LG-expressing T-cells are present before transplantation in CMV-seronegative recipients and predict early CMV DNAemia.
Maria Margarita Anders, Argentina
Liver and Kidney Transplantation with Organs from Chagas Disease Positive Donors: A Valuable Resource That Requires Close Monitoring
Maria Margarita Anders, Argentina
Liver and Kidney Transplantation with Organs from Chagas Disease Positive Donors: A Valuable Resource That Requires Close Monitoring
Ian McGowan, Denmark
Ex Vivo Targeting of the Latent Cytomegalovirus Reservoir in Human Kidneys to Prevent Virus Reactivation Post Transplantation
Ian McGowan, Denmark
Ex Vivo Targeting of the Latent Cytomegalovirus Reservoir in Human Kidneys to Prevent Virus Reactivation Post Transplantation
18:00-19:00 201
201
18:00
Town Hall: AST Townhall
Full Details
AST WTC2025, United States
Welcome, In Memoria, Executive Committee Presentations
AST WTC2025, United States
Welcome, In Memoria, Executive Committee Presentations
AST WTC2025, United States
Achievement Awards (14)
AST WTC2025, United States
Achievement Awards (14)
AST WTC2025, United States
FAST Recipients, AAKP medal of Excellence, Member get Member Winners
AST WTC2025, United States
FAST Recipients, AAKP medal of Excellence, Member get Member Winners
AST WTC2025, United States
Committee & COP Recognition - WTC Executive Committee Chair Outgoing Board Members Election Results
AST WTC2025, United States
Committee & COP Recognition - WTC Executive Committee Chair Outgoing Board Members Election Results
Email: info@wtc2025.org
514-874-1717